Dextech Medical AB (XSAT:DEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.98
+0.28 (2.89%)
At close: Sep 14, 2026

Dextech Medical AB Financials Overview

Millions SEK. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
--3.225.398.713.12
Revenue Growth
---40.15%-38.18%179.60%390.65%
Gross Profit
-5.86-5.863.225.398.713.12
Operating Income
-6.65-6.65-5.32-5.55-4.94-5.27
Net Income
-6.46-6.46-4.84-4.71-4.59-5.27
Earnings Per Share
-0.35-0.35-0.26-0.25-0.25-0.31
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
8.638.6314.7119.0425.2435.47
Net Cash Growth
-41.32%-41.32%-22.76%-24.54%-28.86%926.20%
Net Cash Per Share
0.470.470.791.011.372.09
Cash & Investments
8.638.6314.7119.0425.2435.47

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.07-1.07-1.11-0.81-1.55-2
Free Cash Flow
-1.07-1.07-1.11-0.81-1.55-2
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---165.01%-103.04%-56.70%-169.14%
Pretax Margin
---150.32%-87.38%-52.70%-169.14%
Profit Margin
---150.31%-87.38%-52.70%-169.14%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
--43.0214.568.9128.60